Edwards Lifesciences Corp EW

Healthcare Medical Devices

Edwards Lifesciences Corporation is a global structural heart innovation company. The Company is engaged in patient-focused medical innovations for structural heart disease and invests in research and development to transform care for those impacted by structural heart disease. Its products are categorized into groups, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart (Surgical). It develops transcatheter heart valve replacement technologies designed for the minimally invasive replacement of aortic heart valves. The Edwards SAPIEN family of valves includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. Its PASCAL PRECISION and Cardioband transcatheter valve repair systems are commercially available in Europe for mitral and tricuspid valve repair.

NYSE:EW - Post by User

Edwards Lifesciences Corp

<< Previous

Bullboard Posts

Next >>

Post by whytestockson Jul 25, 2024 5:46pm

46 Views

Post# 36148886

EW Price Target Alert: $90.00. Issued by Oppenheimer

NEWS: $EW EW Price Target Alert: $90.00. Issued by Oppenheimer2024-07-25 16:00:05 ET Suraj Kalia from Oppenheimer issued a price target of $90.00 for EW on 2024-07-25 13:36:00. The adjusted price target was set to $90.00. At the time of the announcement, EW was trading at $60.58. The overall price target consensus is at $109.85 wit...EW - EW Price Target Alert: $90.00. Issued by Oppenheimer

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant